Screening for common genetic variants in addition to rare genetic variants can help improve patient risk stratification for ...

A rapidly growing heart failure epidemic calls for prioritizing primary prevention, according to a new scientific statement ...

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030. A new analysis published in Circulation: Heart Failure shows ...

Heart attacks remain a significant health concern in the United States. According to the Centers for Disease Control and ...

Hearing impairment increases a person’s risk of heart failure, a new study has found. The study found that psychological distress caused by hearing impairment plays a “notable” role in ...

Both of these late-stage studies are using this drug to treat patients with pulmonary hypertension (PH) with heart failure with preserved ejection fraction (PH-HFpEF). This program is coming along ...

a disease where there remains a significant need for new treatment options,” said Roland Chen, MD, senior vice president, drug development, Immunology and Cardiovascular Medicines, Bristol Myers ...

The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to prioritize its primary prevention. Whereas a risk-based approach for HF prevention ...

Glenmark Pharmaceuticals recalled two dozen generic medicines-- including ones for diabetes, heart disease, hypertension ... aimed at lowering prescription drug prices that included changes ...

But when should you be concerned? Experts warn that in some cases, swollen feet may indicate heart failure or other serious medical issues. Let’s explore the connection between swollen feet and ...

Bristol Myers Squibb BMY suffered a setback in the late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos (mavacamten ... with symptomatic New York Heart Association (NYHA) class ...